Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Vascular diseases
  • Type : Health technology assessment
  • Active substance : clopidogrel
  • Active substance : ivabradine
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Protheses and implants (1)
    • Surgical procedures (1)
    • Plus ...
      • Cardiac surgery (1)
  • Diseases and conditions (1)
  • Plus ...
    • Heart diseases (1)
    • Plus ...
      • Heart valves diseases (1)
    • Vascular diseases (1)
    • Plus ...
      • Aortic diseases (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Manufacturer
  • inconnu (1)
  • industriels (1)
Language
  • Français (1)
Active substance
  • alcool isopropylique (1)
  • aspirine (1)
  • ciclosporine (1)
  • clopidogrel (1)
  • ivabradine (1)
  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
Sorted by :Relevance
  • Title
  • Date

  • Assessment of transcatheter aortic valve implantation

    Health technology assessment - Posted on 05/01/2012
    Download document
    Add to my selection
  • « Première page
  • < Page précédente
  • / 1
  • > Page suivante
  • » Dernière page
  • 10 par pages
    • 10 par pages
    • 20 par pages
    • 50 par pages
    • 100 par pages
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
r3sSNHAW3m7Bk7J1